跳至主要内容
临床试验/NCT02892266
NCT02892266已完成不适用

Prevalence and Correlates of Post-Traumatic Stress Symptoms (PTSS) in Adolescent Solid Organ Transplant Recipients (CTOTC-11)

National Institute of Allergy and Infectious Diseases (NIAID)13 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
124
试验地点
13
主要终点
Medication Level Variability Index (MLVI)

研究概览

简要总结

This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.

Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
12 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • The patient:
  • and/or their parent(s)/guardian must be able to understand and provide informed consent in English or Spanish;
  • is prescribed tacrolimus (either brand or generic formulation); and
  • has been seen in the enrolling center's clinic at least twice in the last two years.

排除标准

  • The patient:
  • received a transplant less than 18 months prior to enrollment;
  • has had more than one transplant (including marrow replacement);
  • or their parent(s)/guardian is actively psychotic or severely disoriented due to any cause, including hepatic encephalopathy (temporary exclusion);
  • or their parent(s)/guardian has been diagnosed with severe intellectual disability as defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5);
  • is not medically stable or is hospitalized;
  • is currently enrolled in a study that aims to improve adherence to medical recommendations;
  • is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of Post-Traumatic Stress Disorder (PTSD) at enrollment;
  • is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.

结局指标

主要结局

Medication Level Variability Index (MLVI)

时间窗: 6 months retrospective data to 6 months post enrollment

Defined by fluctuation in medication blood levels. Calculated as the standard deviation (variation) of a minimum of 3 outpatient tacrolimus trough levels, obtained for one year, consisting of 6 months prior to study enrollment plus 6 months post study enrollment.

University of California at Los Angeles Post-Traumatic Stress Disorder Reaction Index DSM-5 (UCLA PTSD RI DSM-5) Total Score

时间窗: At enrollment visit

The UCLA PTSD RI DSM-5 is a widely used and validated self-report questionnaire assessing posttraumatic stress symptoms (PTSS) in children and adolescents ages 8-18 years.

次要结局

  • Child Depression/Distress Assessment(At enrollment visit)
  • Above-threshold Medication Level Variability Index (MLVI)(6 months post enrollment)
  • Diagnosis of chronic allograft rejection(6 months retrospective data to 6 months post enrollment)
  • QOL Assessment Using PedsQL Subscale Scores(At enrollment visit)
  • Above-threshold Child PTSS Score(At enrollment visit)
  • Child Avoidance Score(At enrollment visit)
  • Diagnosis of graft failure(6 months retrospective data to 6 months post enrollment)
  • Parent PTSS Total Score(At enrollment visit)
  • QOL Assessment Using the HRQOL (PedsQL) Total Score(At enrollment visit)
  • Parent Avoidance(At enrollment visit)
  • Quality of Life (QOL) Assessment Using the PedsQL Total Score(At enrollment visit)
  • PedsQL Family Impact Total Score(At enrollment visit)
  • PedsQL Family Impact Subscale Scores(At enrollment visit)
  • Types of traumas identified as salient by the parent(At enrollment visit)
  • Types of traumas identified as salient by the child(At enrollment visit)

研究者

申办方类型
Nih
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验